Entinostat in Combination With Aldesleukin in Treating Patients With Metastatic Kidney Cancer

NCT01038778 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

47

Enrollment

NIH

Sponsor class

Conditions

Clear Cell Renal Cell Carcinoma
Metastatic Kidney Carcinoma
Stage III Renal Cell Cancer AJCC v7
Stage IV Renal Cell Cancer AJCC v7

Interventions

BIOLOGICAL: Aldesleukin
PROCEDURE: Computed Tomography
DRUG: Entinostat
RADIATION: Fludeoxyglucose F-18
OTHER: Laboratory Biomarker Analysis
OTHER: Pharmacological Study
PROCEDURE: Positron Emission Tomography

Sponsor

National Cancer Institute (NCI)